Description
Lucentis 10 mg/ml.
Lucentis is a prescription medication that contains the active ingredient Ranibizumab. It is available in a concentration of 10 mg/ml. and is administered as 0.23 ml. using 2 needles. Lucentis is primarily used to treat certain eye conditions, such as wet age-related macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion.
How Lucentis Works
Lucentis belongs to a class of medications known as anti-VEGF (vascular endothelial growth factor) agents. VEGF is a protein that plays a key role in the growth of abnormal blood vessels in the eye. By blocking the action of VEGF, Lucentis helps to reduce the growth of these abnormal blood vessels, which can improve vision in patients with certain eye conditions.
Indications
Lucentis is indicated for the treatment of the following eye conditions:
- Wet age-related macular degeneration
- Diabetic macular edema
- Macular edema following retinal vein occlusion
Administration and Dosage
Lucentis is administered by injection into the eye by a healthcare professional. The recommended dose is 0.5 mg. (0.05 ml) once a month. The medication is supplied in single-use vials containing 2 needles for administration. The dose may be adjusted based on the individual patient’s response to treatment.
Possible Side Effects
Like all medications, Lucentis can cause side effects. Some common side effects of Lucentis include:
- Eye pain or redness
- Increased tears
- Floaters in the eye
- Blurred vision
- Headache
Serious side effects of Lucentis may include eye infections, retinal detachment, and increased eye pressure. Patients should seek immediate medical attention if they experience any severe or persistent side effects.
Precautions
Before using Lucentis, patients should inform their healthcare provider about any existing medical conditions and medications they are taking. Lucentis may not be suitable for patients with certain eye conditions or a history of eye infections. Pregnant or breastfeeding women should consult with their healthcare provider before using Lucentis.
Storage and Handling
Lucentis should be stored in the refrigerator at a temperature between 2°C to 8°C (36°F to 46°F). The medication should be protected from light and moisture. Do not freeze Lucentis. Keep the medication out of reach of children and pets.
Conclusion
Lucentis is a valuable medication for the treatment of various eye conditions, including wet age-related macular degeneration and diabetic macular edema. By blocking the action of VEGF, Lucentis helps to improve vision and prevent further damage to the eye. Patients should follow the dosing instructions provided by their healthcare provider and report any side effects promptly. If you have any questions or concerns about Lucentis, consult with your healthcare provider for personalized guidance.
